Related Experiment Videos

Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis

Kirsten I Kaptein1, Peter de Jonge, Rob H S van den Brink

  • 1Department of Psychiatry, University Medical Center Groningen, University of Groningen, The Netherlands.

Psychosomatic Medicine
|September 22, 2006
PubMed

Insights

Patients with increasing depressive symptoms after myocardial infarction (MI) face a higher risk of new cardiac events. Identifying and treating this subgroup is crucial for improving cardiac prognosis.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Depressive symptoms following myocardial infarction (MI) are linked to adverse cardiovascular outcomes.
  • The trajectory of these symptoms and their impact on long-term cardiac prognosis remain unclear.

Purpose of the Study:

  • To identify distinct patterns (courses) of depressive symptoms after MI.
  • To investigate the association between these symptom trajectories and subsequent cardiac events.

Main Methods:

  • Latent class analysis (LCA) was used to analyze Beck Depression Inventory (BDI) scores from 475 patients in the Depression after Myocardial Infarction (DepreMI) study.
  • Data were collected during hospitalization and at 3, 6, and 12 months post-MI.
  • The link between identified symptom classes and cardiac prognosis was examined.

Main Results:

  • Five distinct courses of depressive symptoms were identified, with the "significant and increasing depressive symptoms" class comprising 4.0% of patients.
  • This subgroup demonstrated a significantly higher risk of new cardiovascular events (HR = 2.73, p = .01), even after adjusting for baseline factors (HR = 2.46, p = .03).
  • Prevalence of significant depressive symptoms ranged from 22.7% to 25.5% throughout the post-MI year.

Conclusions:

  • Patients experiencing significant and increasing depressive symptoms post-MI are at a substantially elevated risk for recurrent cardiac events.
  • This specific subgroup warrants targeted evaluation for antidepressant interventions to potentially improve cardiac outcomes.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...